RT Journal Article
SR Electronic
T1 Survey of Clinical Protocols for the Use of <sup>177</sup>Lu-PSMA-617 in the United States
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 208
OP 211
DO 10.2967/jnmt.123.266769
VO 52
IS 3
A1 Kuo, Phillip H.
A1 Covington, Matthew F.
A1 Lee, Daniel J.
A1 Wong, Terence Z.
A1 Pandit-Taskar, Neeta
YR 2024
UL http://tech.snmjournals.org/content/52/3/208.abstract
AB Although guidelines for the use of 177Lu-PSMA-617 published by various organizations are important, they do not include all the essential, practical points necessary for a complete institutional protocol. Therefore, a brief survey was performed to assess key components of the 177Lu-PSMA-617 protocol before, during, and after delivery of therapy. This survey demonstrated the wide variability in many aspects of institutional protocols regarding determination of eligibility for and administration of 177Lu-PSMA-617 therapy. The real-world protocol details provided here from a variety of institutions may help new and established theranostic programs.